Additional file 2 of Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects on cell death, self-renewal, and invasion
posted on 2023-11-22, 04:46authored byNadia Sousa, Carsten Geiß, Laura Bindila, Ingo Lieberwirth, Ella Kim, Anne Régnier-Vigouroux
Additional file 2. Sphingolipid analysis by liquid chromatography/multiple reaction monitoring (LC/MRM). MRM transitions and parameters used in positive ion mode for sphingolipid profile and quantification are depicted.